General Information of the Compound
Compound ID
CP0549285
Compound Name
SEP-363856
    Show/Hide
Synonyms
SEP-363856
    Show/Hide
Structure
Formula
C9H13NOS
Molecular Weight
183.276
Canonical SMILES
CNC[C@@H]1OCCc2ccsc12
    Show/Hide
InChI
InChI=1S/C9H13NOS/c1-10-6-8-9-7(2-4-11-8)3-5-12-9/h3,5,8,10H,2,4,6H2,1H3/t8-/m0/s1
    Show/Hide
InChIKey
ABDDQTDRAHXHOC-QMMMGPOBSA-N
CAS
1310426-33-5
Physicochemical Property
logP
1.5813
Rotatable Bonds
2
Heavy Atom Count
12
Polar Areas
21.26
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
12

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 89532783
ChEMBL ID
CHEMBL4650337
DrugBank ID
DB15665
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04763, Trace amine-associated receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  1
1
EC50 = 38 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( SEP-363856 )
Drug Name SEP-363856
Company Sunovion
Indication
Schizophrenia
Phase 3
Parkinson disease
Phase 2
Major depressive disorder
Phase 1
Target(s)
5-HT 1A receptor (HTR1A)
Agonist
Trace amine-associated receptor-1 (TAAR1)
Agonist